Benoı̂t Blanchet

Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes

Jean‐Philippe Collet, Gilles Montalescot, Benoı̂t Blanchet et al. · Circulation · 2004 · 371 citations

Medicine, Cardiology, Pharmacotherapy +12

Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma

Olivier Mir, Romain Coriat, Benoı̂t Blanchet et al. · PLoS ONE · 2012 · 298 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus

M. Jallouli, Lionel Galicier, Noël Zahr et al. · Arthritis & Rheumatology · 2015 · 139 citations

Medicine, Pharmacokinetics, Pharmacology +13

Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practice

Benoı̂t Blanchet, Bertrand Billemont, Julie Cramard et al. · Journal of Pharmaceutical and Biomedical Analysis · 2009 · 119 citations

Pharmacy, Pharmacokinetics, Pharmacology +7

Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study

Manuela Tiako Meyo, Anne Jouinot, Etienne Giroux‐Leprieur et al. · Cancers · 2020 · 112 citations · Full text

Medicine, Oncology, Pharmacology +17